Teladoc Health and Livongo Merge The combination of Teladoc Health and Livongo creates a global leader in consumer-centered virtual care. The combined company is positioned to execute quantified opportunities to drive revenue synergies of $100 million by the end of the second year following the close, reaching $500 million on a run-rate basis by 2025. Price: $18.5B in value based on each share of Livongo will be exchanged for 0.5920x shares of Teladoc Health plus cash consideration of
Read More
Kantar Health
M&A: Cerner to Acquire Health Division of Kantar for $375M in Cash
What You Should Know: - Cerner announces it will acquire Kantar Health, a leading data, analytics, and real-world evidence and commercial research consultancy serving the life science and health care industry. - This acquisition is expected to allow Cerner’s Learning Health Network client consortium and health systems with more opportunities to directly engage with life sciences for funded research studies. The acquisition is expected to close during the first half of
Read More
Syapse Appoints David Pomerantz as Chief Commercial Officer
Syapse, a real-world evidence company accelerating the delivery of precision medicine through the Syapse Learning Health Network™, today announced the appointment of David Pomerantz as Chief Commercial Officer. In his new role as Chief Commercial Officer, Pomerantz will lead the future direction of Syapse’s commercial endeavors and expand its life sciences partnerships across the Syapse Learning Network. Pomerantz Bio/Background Mr. Pomerantz brings more than 25 years of account
Read More
Kantar Health and Nokia Partner on Biometric and Longitudinal Data Diabetes Study
Kantar Health, a global healthcare consulting firm is teaming up with Nokia on a comprehensive longitudinal cohort study to better understand the impact of "Lifestyle Therapy" on diabetes treatment and patient outcomes. The study will highlight how the combination of biometric and longitudinal, real-world data can drive better consumer insights through a holistic, 360-degree view of the diabetes patient. This would enable healthcare companies to make better decisions for managing and treating
Read More
